Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,577
Closed -$166K 693
2017
Q1
$166K Sell
3,577
-34,644
-91% -$1.55M 0.04% 198
2016
Q4
$1.48M Buy
38,221
+22,219
+139% +$911K 0.29% 68
2016
Q3
$690K Sell
16,002
-16,554
-51% -$679K 0.1% 132
2016
Q2
$1.2M Sell
32,556
-33,036
-50% -$1.22M 0.2% 78
2016
Q1
$2.41M Buy
65,592
+20,877
+47% +$654K 0.32% 56
2015
Q4
$1.57M Sell
44,715
-27,903
-38% -$931K 0.21% 67
2015
Q3
$2.54M Buy
72,618
+68,987
+1,900% +$2.39M 0.32% 58
2015
Q2
$127K Buy
+3,631
New +$156K 0.01% 240
2015
Q1
Sell
-54,040
Closed -$2.44M 572
2014
Q4
$1.89M Buy
+54,040
New +$2.54M 0.26% 69

Other funds holding YHOO

Exane Derivatives's YHOO Position: Q2 2017 in Review

Exane Derivatives sold out of Yahoo Inc (YHOO) in Q2 2017, closing a stake of 3,577 shares — an estimated $166K sold.

Exane Derivatives first reported a position in YHOO in Q4 2014 and held it in 9 quarters. The position peaked at $2.54M in Q3 2015. 8 funds tracked by Wall St. Rank hold YHOO as of Q2 2017.

  • Exane Derivatives reported no remaining Yahoo Inc position as of Q2 2017 after selling out during the quarter.
  • Exane Derivatives sold 3,577 Yahoo Inc shares in Q2 2017, an estimated $166K.
  • Exane Derivatives first reported a position in Yahoo Inc in Q4 2014 and held it in 9 quarters.
  • Exane Derivatives's Yahoo Inc position peaked at $2.54M in Q3 2015.
  • 8 funds tracked by Wall St. Rank held Yahoo Inc as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.